Radiation Oncology Journal

The Korean Society for Radiation Oncology (대한방사선종양학회)
권호 표지
DOI QR코드

DOI QR Code

Results of Breast Conserving Surgery and Subsequent Postoperative Radiotherapy for Cases of Breast Cancer

유방암에서 유방보존수술 및 수술 후 방사선치료의 결과

  • Chie, Eui-Kyu (Department of Radiation Oncology, Seoul National University College of Medicine) ;
  • Kim, Kyu-Bo (Department of Radiation Oncology, Seoul National University College of Medicine) ;
  • Choi, Jin-Hwa (Department of Radiation Oncology, Seoul National University College of Medicine) ;
  • Jang, Na-Young (Department of Radiation Oncology, Seoul National University College of Medicine) ;
  • Han, Won-Shik (Department of Surgery, Seoul National University College of Medicine) ;
  • Noh, Dong-Young (Department of Surgery, Seoul National University College of Medicine) ;
  • Im, Seock-Ah (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Kim, Tae-You (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Bang, Yung-Jue (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Ha, Sung-Whan (Department of Radiation Oncology, Seoul National University College of Medicine)
  • 지의규 (서울대학교 의과대학 방사선종양학교실) ;
  • 김규보 (서울대학교 의과대학 방사선종양학교실) ;
  • 최진화 (서울대학교 의과대학 방사선종양학교실) ;
  • 장나영 (서울대학교 의과대학 방사선종양학교실) ;
  • 한원식 (서울대학교 의과대학 외과학교실) ;
  • 노동영 (서울대학교 의과대학 외과학교실) ;
  • 임석아 (서울대학교 의과대학 내과학교실) ;
  • 김태유 (서울대학교 의과대학 내과학교실) ;
  • 방영주 (서울대학교 의과대학 내과학교실) ;
  • 하성환 (서울대학교 의과대학 방사선종양학교실)
  • Published : 2008.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: We analyzed the treatment outcomes and prognostic factors of breast conserving surgery, followed by postoperative radiotherapy.Materials and Methods: A total of 424 breast cancer patients treated with breast conserving surgery and postoperative radiotherapy between February 1992 and January 2001 were retrospectively analyzed. A quadrantectomy and axillary lymph node dissection was performed in 396 patients. A total of 302 patients had T1 disease, and 122 patients had T2 disease. Lymph node involvement was confirmed in 107 patients. Whole breast irradiation was administered at up to 50.4 Gy in 28 fractions, followed by a 10 Gy boost in 5 fractions to the tumor bed. In addition, 57 patients underwent regional lymph node irradiation. Moreover, chemotherapy was administered in 231 patients. A regimen consisting of cyclophosphamide, methotrexate, and 5-fluorouracil was most frequently used with 170 patients. The median follow-up time was 64 months. Results: The 5-year local control rate was 95.6%. During the follow-up period, local tumor recurrence was observed in 15 patients. The 5-year overall and disease-free survival rates were 93.1% and 88.7%, respectively. The 5-year overall survival rates, by stage, were 94.8% for stage I, 95.0% for stage IIA, 91.1% for stage IIB, 75.9% for stage IIIA, and 57.1% for stage IIIC. As for disease-free survival, the corresponding figures, by stage (in the same order), were 93.1%, 89.4%, 82.8%, 62.0%, and 28.6%, respectively. The advanced N stage (p=0.0483) was found to be a significant prognostic factor in predicting poor overall survival, while the N stage (p=0.0284) and age at diagnosis (p=0.0001) were associated with disease-free survival. Conclusion: This study has shown that breast conserving surgery and postoperative radiotherapy for early breast cancer results was excellent for local control and survival.

목 적: 조기유방암의 치료에 있어 과거에는 유방 전적출술이 주된 치료였으나 현재는 유방보존술이 표준 치료방법으로 정립되었다. 저자들은 서울대학교병원에서 유방보존수술 및 방사선치료를 받은 환자의 임상적 특성을 조사하고 치료결과 및 예후인자를 분석하고자 하였다. 대상 및 방법: 1992년 2월부터 2002년 1월까지 침윤성 유방암으로 유방보존수술 및 수술 후 방사선치료를 받은 424명을 대상으로 후향적으로 분석하였다. 대부분의 환자는 사분절제술 및 액와림프절 청소술을 시행 받았다(396명, 93.4%). 302명이 T1이었고 122명은 T2 병기였으며, 림프절 전이는 107명에서 확인되었다. 방사선치료는 전체 유방에 28회에 걸쳐 50.4 Gy를 조사한 후 종양이 있었던 부위에 10 Gy의 추가조사를 실시하였다. 영역림프절 조사는 57명에서 시행되었다. 항암화학요법은 231명에서 시행되었으며, 그 중 170명이 cyclophosphamide, methotrexate 및 5-fluorouracil을 투여 받았다. 중앙추적기간은 64개월이었다. 결 과: 전체 환자의 5년 국소제어율은 95.6%이었다. 추적관찰 중 15명의 환자에서 국소재발이 확인되었다. 5년 생존율은 93.1%이었고, 병기에 따른 5년 생존율은 I기 94.8%, IIA기 95.0%, IIB기 91.1%, IIIA기 75.9%, IIIC기 57.1%이었다. 5년 무병생존율은 88.7%이었고, 병기별로는 I기 93.1%, IIA기 89.4%, IIB기 82.8%, IIIA기 62.0%, IIIC기 28.6%이었다. 예후인자 분석에서는 N 병기(p=0.0483)가 생존율에, 연령(p=0.0284)과 N 병기(p=0.0001)가 무병생존율에 각각 유의한 영향을 보였다. 결 론: 조기유방암에서 유방보존수술 및 수술 후 방사선치료는 우수한 국소제어율 및 생존율을 기대할 수 있는 치료법임을 확인할 수 있었다.

Keywords

References

  1. Fisher B, Anderson S, Bryant J, et al. Twenty-year followup of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-1241 https://doi.org/10.1056/NEJMoa022152
  2. Arriagada R, Le MG, Rochard F, Contesso G. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol 1996;14:1558-1564 https://doi.org/10.1200/JCO.1996.14.5.1558
  3. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347:1227-1232 https://doi.org/10.1056/NEJMoa020989
  4. Blichert-Toft M, Rose C, Andersen JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. J Natl Cancer Inst Monogr 1992;11:19-25
  5. National Institutes of Health Consensus Development Panel. Consensus statement: Treatment of early-stage breast cancer. J Natl Cancer Inst Monogr 1992;11:1-5
  6. Bartelink H, van Dam F, can Dongen J. Psychological effects of breast conserving therapy in comparison with radical mastectomy. Int J Radiat Oncol Biol Phys 1985;11:381-385 https://doi.org/10.1016/0360-3016(85)90161-0
  7. Joslyn SA. Geographic differences in treatment of early stage breast cancer. Breast J 1999;5:29-35 https://doi.org/10.1046/j.1524-4741.1999.005001029.x
  8. Ministry of Health and Welfare. 2002 Annual Report of the Korea Central Cancer Registry (Published in 2003)
  9. Ahn SH, Yoo KY. The Korean Breast Cancer Society. Chronological changes of clinical characteristics in 31115 new breast cancer patients among Koreans during 1996-2004. Breast Cancer Res Treat 2006;99:209-214 https://doi.org/10.1007/s10549-006-9188-x
  10. Koh KW, Kim MS, Yoo SY, et al. The results of primary radiotherapy following breast-conserving surgery for early breast cancer. J Korean Soc Ther Radiol Oncol 1995;13: 163-171
  11. Suh CO, Chung EJ, Lee HD, Lee KS, Oh KK, Kim GE. Risk factors for recurrence after conservative treatment in early breast cancer: preliminary report. J Korean Soc Ther Radiol Oncol 1994;12:337-347
  12. Kim JH, Kim OB, Kim YS. Breast conserving operation and radiation therapy in early breast cancer: interim analysis. J Korean Soc Ther Radiol Oncol 2001;19:27-33
  13. Lee MZ, Chun HC. Radiation therapy for operable breast cancer after conservative surgery. J Korean Soc Ther Radiol Oncol 2004;20:309-315
  14. Kim YS, Yoon SC, Chung SM, Ryu MR, Jung SS, Choi IB. Breast conservation therapy versus mastectomy: preliminary results of pattern of failure and survival rate in early breast cancer. J Korean Soc Ther Radiol Oncol 2004;22:115-123
  15. Kim KJ, Huh SJ, Yang JH, et al. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Jpn J Clin Oncol 2005;35:126-133 https://doi.org/10.1093/jjco/hyi039
  16. Lee SH, Lee KC, Choi J, et al. Radiation therapy and chemotherapy after breast conserving surgery for invasive breast cancer: an intermediate result. J Korean Soc Ther Radiol Oncol 2007;25:16-25
  17. American Joint Committee on Cancer (AJCC). AJCC Cancer Staging Manual. 6th ed. New York; Springer-Verlag, 2002: 223-240
  18. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-1346 https://doi.org/10.1016/0360-3016(95)00060-C
  19. van Dongen JA, Voogd AC, Fentiman IS, et al. Longterm results of a randomized trial comparing breastconserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000;92:1143-1150 https://doi.org/10.1093/jnci/92.14.1143
  20. Poggi MM, Danforth DN, Sciuto LC, et al. Eighteenyear results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 2003;98:697-702 https://doi.org/10.1002/cncr.11580
  21. Veronesi U, Volterrani F, Luini A, et al. Quadrantectomy vs. lumpectomy for small size breast cancer. Eur J Cancer 1990;26:671-673 https://doi.org/10.1016/0277-5379(90)90114-9
  22. Freedman G, Fowble B, Hanlon A, et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 1999;44:1005-1015 https://doi.org/10.1016/S0360-3016(99)00112-1
  23. Park CC, Mitsumori M, Nixon A, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 2000;18:1688-1675
  24. Leong C, Boyages J, Jayasinghe UW, et al. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma. Cancer 2004;100:1823-1832 https://doi.org/10.1002/cncr.20153
  25. Cianfrocca M, Goldstein LJ. Prognostic and predictive factors in early-stage breast cancer. Oncologist 2004;9:606-616 https://doi.org/10.1634/theoncologist.9-6-606
  26. Zhou P, Recht A. Young age and outcome for women with early-stage invasive breast carcinoma. Cancer 2004;101:1264-1274 https://doi.org/10.1002/cncr.20523
  27. Solin LJ, Fowbie B, Schultz DJ, Goodman RL. Age as a prognostic factor for patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phy 1989;16:373-381 https://doi.org/10.1016/0360-3016(89)90333-7
  28. Nixon AJ, Neuberg D, Hayes DF, et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 1994;12:888-894 https://doi.org/10.1200/JCO.1994.12.5.888
  29. Hankey BF, Miller B, Curtis R, Kosary C. Trends in breast cancer in younger women in contrast to older women. J Natl Cancer Inst Monogr 1994;16:7-14
  30. Nattinger AB, Kneusel RT, Hoffmann RG, et al. Relationship of distance from a radiotherapy facility and initial breast cancer treatment. J Natl Cancer Inst 2001;93:1344-1346 https://doi.org/10.1093/jnci/93.17.1344
  31. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Thurlimann B, Senn HJ. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 2005;16:1569-1583 https://doi.org/10.1093/annonc/mdi326
  32. Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 2001;12:997-1003 https://doi.org/10.1023/A:1011136326943
  33. Hughes K, Schnaper L, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 2004;351:971-977 https://doi.org/10.1056/NEJMoa040587
  34. Fyles AW, McCready DR, Manchul LA, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 2004;351:963-970 https://doi.org/10.1056/NEJMoa040595
  35. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet 2005;366:2087-2106 https://doi.org/10.1016/S0140-6736(05)67887-7
  36. Wolmark N, Wang J, Mamounas E, Bryant J, Fisher B. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 2001;30:96-102
  37. van der Hage JA, van der Velde CJH, Julien JP, Tubiana-Hulin M, Vandervelden C, Duchateau L. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 2001;19:4224-4237 https://doi.org/10.1200/JCO.2001.19.22.4224

Cited by

  1. Long-term Results of Breast-conserving Surgery and Radiation Therapy in Early Breast Cancer vol.27, pp.3, 2008, https://doi.org/10.3857/jkstro.2009.27.3.153
  2. 유방암 환자의 Field-in-Field Technique 치료 시 호흡의 움직임에 따른 선량 평가 vol.41, pp.6, 2008, https://doi.org/10.17946/jrst.2018.41.6.561